Table 4: Parameters for insulin action and secretion before and after treatment of responder and non-responders.
| Before Treatment | After Treatment |
| Non-responder | Responder | p-valuec | Non-responder | Responder | p-valuec |
First phase insulin secretion a | 19.2 (7.5-40.6) | 12.4 (5.1-40.7) | NS | 46.0 (20.8-70.7) | 50.0 (2.4-72.1) | NS |
Second phase insulin secretion b | 0.082 (0.058-0.107) | 0.006(-0.0006-0.045) | 0.0019 | 0.063 (0.015-0.077) | 0.096 (0.063-0.127)d | 0.0492 |
HOMA-IR | 0.96 (0.47-1.36) | 0.68 (0.22-3.04) | NS | 0.85 (0.52-2.95) | 1.2 (0.75-2.84) | NS |
HOMA-B | 5.36 (1.26-17.75) | -0.25 (-1.81-4.14) | 0.0651 | 4.74 (4.41-18.8) | 8.17 (3.41-13.74)d | NS |
Insulin sensitivity | 4.5 (1.8-5.4) | 1.8 (1.0-2.5) | NS | 2.6 (1.3-3.1) | 2.1 (1.6-6.2) | NS |